drugset / Trial / NCT00759161

Safety and Efficacy Study of A Novel Ointment to Treat Plaque Type Psoriasis

NCT00759161

Phase 2 Completed 35 enrolled Pfizer
RandomizedParallel-groupTriple-blindTreatment

Summary

The purpose of the study is to determine the safety and efficacy of AN2728 Ointment, 5%, compared to Ointment Vehicle in the treatment of plaque type psoriasis.

Timeline

Start
2007-11
Primary completion
2008-03
Completion
2008-03

Drugs

EvaluationDrugModalityDoseRoute
Comparator Crisaborole Small molecule 5 % Topical

Indications